Our work on genomic compartments is now out in @NAR_Open! I really have to commend both the reviewers and NAR team for very professional and speedy handling of the manuscript 👏👏👏 academic.oup.com/nar/advance-ar…

We had a great time at the #ILANIT2023 meeting. Very proud of my team with 4 talks, 3 posters, 3 runners and one fun lab outing which as usual, we forgot to take a photo of.

Check out our new #preprint on the metabolism of immune cells in the TME of patients treated with #immunotherapy led by Ofir Shorer. We analyzed scRNA-seq from >1M cells and found a metabolic signature predictive of response across cancer types. biorxiv.org/content/10.110…

Before we have to pay to tweet, I want to post an opening for a PhD position at the Weizmann Institute for a student interested in characterizing the tumor MACROenvironment for therapeutic implications.

An Open Letter to Every Parent In America Please help me get this message out to every parent in the United States. Please help me protect your children. I am BEGGING you - "liking" this is not enough. Please retweet right NOW. youtube.com/watch?v=uo7fdx…

הסרט הזה הוא חובה אזרחית - אין פה חומרים מזעזעים ורגישים - כנסו להקשיב לכרמית שאביה נרצח, אמה נחטפה ואחיה נעדר

In these darkest days our country have ever known, we somehow manage to do science. Our new paper shows how #metabolism of immune cells predicts patients response to ICI. Ofir finished this paper while in reserve duty helping to bring our people back home cell.com/iscience/fullt…

נעם דן, ממשפחתם של סהר וארז קלדרון ששוחררו אך אביהם עופר עדיין חטוף, טלטלה אתמול את אולפן חדשות 12. הנה שוב קטע מדבריה, עם כתוביות. לצפות, להפיץ לכל עבר

We are thrilled to announce that OncoHost has been named one of the Top 10 Precision Oncology Solutions Companies of 2023 by HealthcareTechOutlook! 🏆 Thank you for this honor 💙 Read more: bit.ly/4a4BjdT #PrecisionOncology #HealthcareInnovation #CancerResearch #Proteomics

Happy to share this work lead by Daniel Schaffer, using a deep learning model to identify microbial RNAseq reads that are assembled into longer contigs. We find that the presence of several microbial genes strongly predicts outcomes in esophageal cancer nature.com/articles/s4370…

My second cousin Yagev Buchshtab was kidnapped on October 7 and is being held in Gaza for 81 days now. Please listen to his sister Nufar and share.

We celebrate the much-deserved selection of Gaddy Getz to this year’s class of 2024 AACR Academy Fellows!! Congrats, Gaddy 🎉! aacr.org/about-the-aacr… Mass General Cancer Center Broad Institute

I’m happy to share our new paper showing moonlighting function of ASS1 in the nucleus. Under the tough circumstances we are facing this paper would have never been published without the help of a wonderful editor, great collaborators and resilient students. Thank you all! ♥️

We are excited to share the agenda for our 1st annual event, 26/9 ELSC Brain🪅 w/ spotlights 🔦Yaara Oren, Amos Tanay, @yizhaklab, Matan Hofree 🇮🇱 מתן חופרי & shalev itzkovitz. A field overview by Mor Nitzan & Naomi Habib - Habib Lab 💔, and sc-ience sessions led by Moshe Biton, Oren Ram, Yosef Lab & ofir cohen

🚨 New preprint alert! We performed scRNA-seq & scTCR meta-analysis on cancer patients treated with ICIs, revealing key T cell signatures linked to therapeutic response, with insights into clonal replacement vs reinvigoration! #scRNAseq #Immunotherapy biorxiv.org/content/10.110…

מזמינים אתכם/ן ליום הפתוח למסלול החדש לתואר שני עם התמחות ברפואה חישובית בפקולטה לרפואה בטכניון! 20.3, בשעה 16:00 . לפרטים נוספים : compmed.net.technion.ac.il להרשמה ליום הפתוח: did.li/n8e6q נתראה!

📢 Excited to share our new paper in #npjPrecisionOncology: We present a roadmap for using #scRNAseq and #MachineLearning to study and predict response to immune checkpoint inhibitors. 👉 nature.com/articles/s4169… #CancerImmunotherapy

📢 Excited to share our new paper in Cell Genomics! We analyzed matched #scRNAseq and #scTCRseq from 767K T cells to uncover clonal programs that predict response to immune checkpoint inhibitors. 👉 cell.com/cell-genomics/… #CancerImmunotherapy